aspartyl-aspartic acid: Clinical Trials

3 trials of aspartyl-aspartic acid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 unknown. 2 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Unknown 1
Phase 21Completed 1

Follow aspartyl-aspartic acid: new trials by email Literature Review of aspartyl-aspartic acid trials Research Report on aspartyl-aspartic acid

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Brief Intervention Programme on ASP
Worksheets for ASP, Worksheets for SSB, E-messages for ASP - Alternative Smoking Products
Not applicableUnknownThe University of Hong Kong10002020-05-182020-03-10
MRD/Risk-oriented Therapy of Adult Ph- ALL Including Pegylated Asparaginase and Lineage-targeted Methotrexate
Prephase PDN + CY, Cycle 1 Induction, Cycle 2 Induction / Early consolidation - Untreated Philadelphia Positive Acute Lymphoblastic Leukemia, De Novo
Phase 2CompletedGruppo Italiano Malattie EMatologiche dell'Adulto2042014-05-202021-09-08
Iron Absorption From Iron-enriched Aspergillus Oryzae
Ferrous sulfate - Iron-deficiency, Absorption; Iron
Not applicableCompletedIowa State University172013-05-292017-05-18

Conditions studied

Anemia (1)  ·  Anemia, Iron-Deficiency (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasm, Residual (1)

Sponsors

Gruppo Italiano Malattie EMatologiche dell'Adulto (1)  ·  Iowa State University (1)  ·  The University of Hong Kong (1)

Countries

Hong Kong (1)  ·  Italy (1)  ·  United States (1)

Top investigators

Manju B Reddy, Ph.D. (1)  ·  Renato Bassan, Pr. (1)  ·  Sai Yin Ho, PhD (1)

Results publications

PMID 34048072, PMID 37276451